Back
Predictive Oncology Quote, Financials, Valuation and Earnings
Sponsored
POAI
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
37
POAI
Predictive Oncology
Last Price:
0.88
Seasonality Move:
-7.5%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmPredictive Oncology Price Quote
$0.88
Predictive Oncology Key Stats
Sell
37
Predictive Oncology (POAI)
is a Sell
Day range:
$0.88 - $0.93
52-week range:
$0.85 - $4.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.12
P/B ratio:
1.43%
Volume:
44.7K
Avg. volume:
113.3K
1-year change:
-71.7%
Market cap:
$5.9M
Revenue:
$1.8M
EPS:
$-3.35
How Much Does Predictive Oncology Make?
-
How Much Are Predictive Oncology's Sales Annually?
POAI Revenues are $1.8M -
How Much Profit Does Predictive Oncology's Make A Year?
POAI net income is -$14M
Is Predictive Oncology Growing As A Company?
-
What Is Predictive Oncology's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.43% -
What Is Predictive Oncology's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Predictive Oncology Stock Price Performance
-
Did Predictive Oncology Stock Go Up Last Month?
Predictive Oncology share price went up by 0.57% last month -
Did POAI's Share Price Rise Over The Last Year?
POAI share price fell by -71.7% over the past 1 year
What Is Predictive Oncology 52-Week High & Low?
-
What Is Predictive Oncology’s 52-Week High Share Price?
Predictive Oncology has traded as high as $4.10 over the past 52 weeks -
What Is Predictive Oncology’s 52-Week Low Share Price?
Predictive Oncology has traded as low as $0.85 over the past 52 weeks
Predictive Oncology Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Predictive Oncology?
-
How Much Debt Does Predictive Oncology Have?
Total long term debt quarterly is $276.9K -
How Much Cash Does Predictive Oncology Have?
Cash and short term investments quarterly total is $5.3M -
What Is Predictive Oncology’s Book Value Per Share?
Book value per share is 0.72
Is Predictive Oncology Cash Flow Positive?
-
What Is POAI Cash Flow From Operations?
Cash flow from operations (TTM) is -$12.8M -
What Is Predictive Oncology’s Cash Flow From Financing?
Cash flow from financing (TTM) is $3.4M -
What Is Predictive Oncology’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.1K
Predictive Oncology Return On Invested Capital
-
Is Management Doing A Good Job?
POAI return on invested capital is -161.36% -
What Is Predictive Oncology Return On Assets?
ROA measures how assets are converting to revenues and is -93.92% -
What Is POAI Return On Equity?
ROE is a measure of profitability and is -164.1%
Predictive Oncology Earnings Date & Stock Price
-
What Is Predictive Oncology's Stock Price Today?
A single share of POAI can be purchased today for 0.88 -
What Is Predictive Oncology’s Stock Symbol?
Predictive Oncology trades on the nasdaq under the ticker symbol: POAI -
When Is Predictive Oncology’s Next Earnings Date?
The next quarterly earnings date for Predictive Oncology is scheduled on November 14, 2024 -
When Is POAI's next ex-dividend date?
Predictive Oncology's next ex-dividend date is September 20, 2024 -
How To Buy Predictive Oncology Stock?
You can buy Predictive Oncology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Predictive Oncology Competitors
-
Who Are Predictive Oncology's Competitors?
Below is a list of companies who compete with Predictive Oncology or are related in some way:
Predictive Oncology Dividend Yield
-
What Is POAI Dividend Yield?
Predictive Oncology’s dividend yield currently is 0% -
What Is Predictive Oncology’s Payout Ratio?
Predictive Oncology’s payout ratio is 0% -
When Did Predictive Oncology Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Predictive Oncology’s Dividend Per Share?
Predictive Oncology pays a dividend of $0.00 per share
Predictive Oncology Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | -43.13% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 3.00 |
Upside from Last Price: | 240.91% |